Details of the Drug Reposition

General Information of This Drug (ID: DMT0A3Y)

Drug Name
Etrasimod   DMT0A3Y
Synonyms APD-334; S1P1 receptor agonists (autoimmune diseases), Arena Pharmaceuticals
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Ulcerative colitis DIS8K27O DD71 Approved [1]
------------------------------------------------------------------------------------
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Autoimmune diabetes DISW6UF1 5A10 Phase 2 [2]
Pyoderma gangrenosum DIS8QVTT EB21 Phase 2 [3]
------------------------------------------------------------------------------------

References

1 FDA Approved Drug Products from FDA Official Website. 2023. Application Number: 216956
2 ClinicalTrials.gov (NCT02447302) Safety and Efficacy of APD334 in Patients With Ulcerative Colitis. U.S. National Institutes of Health.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)